Search results
Dr Reddy's, Sun Pharma recall drugs in US market: USFDA | Business Insider India
Business Insider India· 4 days agoAccording to the report, Dr Reddy's Laboratories is recalling drugs to treat insomnia and gout in the American market. New Jersey-based Dr Reddy's Laboratories, Inc., a unit of Hyderabad-based ...
Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime
CNBC Awaaz· 21 hours agoOutlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical...
Sun Pharma.Inds. AGM/EGM: Latest Updates and Details | India Infoline
India Infoline· 3 days agoThis is to inform you that the 31st AGM of the members of Sun Pharmaceutical Industries Limited will be held on Monday, August 28, 2023 at 3.00 p.m. IST through Video Conferencing ...
Stock market update: Nifty Pharma index advances 0.16% in an upbeat market
The Economic Times· 7 days agoThe Nifty Pharma index was trading 0.16 per cent up at 19762.5.
Budget wish list: Pharma industry seeks tax benefits, effective IPR regime
Business Standard India· 21 hours agoThere is a need to incentivise R&D investments, offer corporate tax concessions and establish an...
Ashwin Padmanabhan gets promoted to COO of GroupM South Asia
Financial Express· 6 days agoFrom what it’s understood, Padmanabhan will now oversee a structure that brings together GroupM’s...
Sun Pharmaceuticals Industries Ltd rises for third consecutive session
Business Standard India· 4 days agoSun Pharmaceuticals Industries Ltd is quoting at Rs 1558.7, up 1.61% on the day as on 12:49 IST on...
Sun Pharma Advanced Research Company Ltd Director Discussions | India Infoline
India Infoline· 2 days agoYour Directors take pleasure in presenting the Companys 18th Annual Report and Audited Financial Statements for the financial year ended March 31, 2023. In view of loss incurred during the year ...
Budget wish list: Pharma industry seeks tax benefits, effective intellectual property rights regime
YourStory· 20 hours agoThere is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies.
Sun Pharma.Inds. Auditor Reports: Latest Updates and Details | India Infoline
India Infoline· 3 days agoSun Pharmaceuticals Industries Ltd Auditor Reports: Check out the latest updates, dates, and news about the Sun Pharma.Inds. Auditor Reports at India Infoline